Entering text into the input field will update the search result below

PolarityTE: Risk And Reward

Apr. 06, 2021 8:15 AM ETPolarityTE, Inc. (PTE)RCEL43 Comments


  • Like all microcap biotechs, PolarityTE is a very risky bet.
  • But they have a product with the potential to revolutionize wound care. This is a giant addressable market.
  • I go over the promise, the risks, recent trials, and future plans.
Hospital Emergency Department sign
Photo by georgeclerk/iStock via Getty Images


This is a company with short, tumultuous history, but they also have a product that may revolutionize the wound care industry. The price chart sums the tumult up well.

Data by YCharts

I have been a continuous shareholder since

This article was written by

Deep coverage of complex trends shaping the future with targeted portfolios

Confirmation Bias Is Your Enemy.

Tech and macro. Deep analysis of long term sectoral trends, and the opportunities arising from them. I promise not to bore you. Author of Long View Capital, a Marketplace service for long-term investors. Risk Factors: I am also wrong sometimes.

Analyst’s Disclosure: I am/we are long PTE. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.